Shanghai Oriental Hospital — Shanghai

Public research footprint of Shanghai Oriental Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Head and Neck Squamous Cell Carcinoma · Locally Advanced or Metastatic Solid Tumor · Non-Small Cell Lung Cancer · Locally Advanced Gastric Cancer

Recently updated registry entries

NCT05770310 — A Phase I Study Of JS015 in Patients With Advanced Solid Tumors (Completed)
NCT06711900 — A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination… (Active Not Recruiting)
NCT07668154 — A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shanghai Oriental Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.